Aspirin, methyl salicylate, ethyl benzoate, benzyl benzoate (Preparation, test for purity, assay and medicinal uses)

Curriculum Unit: 16. Study of official compounds:

This study module covers "Aspirin, methyl salicylate, ethyl benzoate, benzyl benzoate (Preparation, test for purity, assay and medicinal uses)", an integral component of the Year 1 Doctor of Pharmacy (Pharm.D) curriculum under Pharmaceutical Organic Chemistry (Study of official compounds). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.

Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:

• Understand fundamental chemical mechanisms, functional pathways, and molecular principles of Aspirin, methyl salicylate, ethyl benzoate, benzyl benzoate (Preparation, test for purity, assay and medicinal uses).
• Examine analytical methodologies, instrumentation, and validation protocols applicable to Study of official compounds.
• Interpret diagnostic indices, assay metrics, and laboratory findings in clinical pharmacy.

Standard literature and institutional sources for Pharmaceutical Organic Chemistry:

• [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
• [2]Vogel's Textbook of Quantitative Chemical Analysis (Mendham et al.)
• [3]Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
• [4]Harper's Illustrated Biochemistry (Rodwell, Bender, Botham, et al.)